Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of salvianolic acid B and analogues of salvianolic acid B in preparing anti-HPV-viral-infection medicine

A technology with a similar structure to salvianolic acid, applied in the field of biomedicine, can solve problems such as untreatable, R&D failure, safety shelving, etc., and achieve the effect of long application history, wide sources, and low price

Inactive Publication Date: 2018-05-18
SOUTHERN MEDICAL UNIVERSITY
View PDF11 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although RNA interference (RNAi) nucleotide analogs can interfere with the expression of HPV virus-related genes to achieve antiviral effects, they only work at the post-transcriptional level and have no impact on the incubation period of the virus. Therefore, RNAi nucleosides Acid analogs cannot be used alone in the treatment of HPV-related diseases
In addition, antioxidants and herbal derivatives have also shown effective therapeutic potential for HPV infection, and the research results of herbal derivatives are the most notable, such as Berberine, Curcumin, Norda Hydrogen Generic acid (NGDA), EGCG, etc., these herbal derivatives can partially inhibit the diseases caused by HPV infection by blocking the transcription of viral genes or antagonizing the function of viral proteins, but these drugs have shown high antiviral efficacy in the research and development stage. effect, but it is forbidden for pregnant women. In addition, the above-mentioned drugs were shelved due to safety and effectiveness issues when they were used in clinical research, resulting in the failure of research and development
[0006] At the same time, a group of antimicrobial candidate drugs, such as Praneem, Carrageenan, curcumin polymeric herbal preparation Basant and JB01-BD, can prevent HPV infection by blocking HPV virus from invading human cells effect, but again, their role is limited to the prevention of HPV infection, and cannot be treated in the case of HPV infection
It is speculated that it may be because the above candidate drugs mainly work before the virus invades the cells, and the effect is not good after the virus invades the cells and reproduces in large numbers

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of salvianolic acid B and analogues of salvianolic acid B in preparing anti-HPV-viral-infection medicine
  • Application of salvianolic acid B and analogues of salvianolic acid B in preparing anti-HPV-viral-infection medicine
  • Application of salvianolic acid B and analogues of salvianolic acid B in preparing anti-HPV-viral-infection medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0038] The present invention will be further described below in conjunction with experiments, but the protection scope of the present invention is not limited thereto.

[0039] Experiment 1: Pseudovirus infection model to detect the inhibitory effect of salvianolic acid B on HPV pseudovirus

[0040] experimental method:

[0041] 1) Gradual dilution of salvianolic acid B, mixed with equal volumes of HPV6 / HPV16 / HPV18 pseudovirus solution and incubated for 30 minutes, then added to the pre-inoculated cell culture plate, and virus control wells and cell blank control wells were set;

[0042] 2) Change the fresh medium after 24 hours, and detect the expression of luciferase in the cells with a luciferase detection kit 48 hours after virus infection.

[0043] Experimental results such as figure 1 As shown, salvianolic acid B can effectively inhibit the infection of cells by three subtypes of HPV pseudoviruses in a concentration-dependent manner, and the IC of HPV6, 16, and 18 viru...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application and salvianolic acid B and analogues of the salvianolic acid B in preparing anti-HPV-viral-infection medicine, and belongs to the field of biomedicine. The inventordiscovers that the salvianolic acid B and the analogues, such as myricetin and dihydromyricetin, of the salvianolic acid B for the first time through researches, the salvianolic acid b and the analogues of the salvianolic acid B have good anti-HPV-viral-infection activity and can effectively block adhering of HPV viruses to target cells, and then HPV viral infection is inhibited. Experiments prove that the salvianolic acid B and capsid protein of the viruses can be directly bound, and adhesion of antagonism viruses to the target cells achieves an anti-virus effect. The salvianolic acid B actsin the early stage that the viruses enter the cells, and can also act in the middle stage and the later stage that the viruses enter the cells. The effects are better than medicine only acting on theearly stage that the viruses enter the cells in the prior art. The salvianolic acid B is harmless to the human body in a concentration range where the salvianolic acid B can achieve the anti-virus function. It is very likely that the salvianolic acid B is developed into a novel microbicide for preventing and treating HPV and other sexually transmitted viral infection.

Description

technical field [0001] The invention belongs to the field of biomedicine, and in particular relates to the application of salvianolic acid B and its structural analogues in the preparation of anti-HPV virus infection drugs. Background technique [0002] Human papillomavirus (human papillomavirus, HPV) is a kind of epitheliophilic virus, belonging to papillomavirus genus of Papovaviridae, is a kind of non-enveloped double-stranded circular epitheliophilic DNA with small molecular weight (7.9Kb) Virus. There are currently about 200 different subtypes of HPV, which are divided into low-risk and high-risk types according to their pathogenicity. Low-risk HPVs mainly cause low-grade lesions at the site of infection, genital or skin warts, and condyloma acuminatum, while high-risk HPVs mainly cause high-grade lesions at the site of infection and invasive cancer. At the same time, the persistent infection of high-risk HPV has been proved to be an important risk factor for the indu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/343A61K31/352A61P31/20A61P35/00A61P15/00
CPCA61K31/343A61K31/352
Inventor 李琳丁永桢殷淑文梁太珍赖芳圆温嘉泳刘叔文
Owner SOUTHERN MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products